Marca Mista depositada no INPI em 14/12/2023 por Seamless Therapeutics GmbH, processo nº 501804706, nas classes 01, 05, 10, 42, 44. Registro em vigor até 14/12/2033.
| Número do processo | 501804706 |
|---|---|
| Situação | Registro de marca em vigor (Madri) |
| Apresentação | Mista |
| Natureza | Madri Produto/Serviço |
| Data do depósito | 14/12/2023 |
| Data da concessão | 05/08/2025 |
| Vigência até | 14/12/2033 |
| Titular | Seamless Therapeutics GmbH |
| CNPJ/CPF do titular | — |
| UF · País | — · DE |
Chemicals for use in industry and science; biological preparations, biological reagents, for use in industry and science.;
Pharmaceutical and biological preparations or active substances for the treatment of diseases; medical, pharmaceutical and biopharmaceutical preparations and substances for the treatment of diseases; pharmaceutical goods and preparations, namely gene transfer, regulation, modulation and delivery medications for the treatment of genetic diseases and disorders; products, agents, for medical purposes, for veterinary purposes; genome editable enzymes; dna recombinant enzymes; dna editable enzymes, especially, recombinases and integrases; genome editable enzymes for the treatment of diseases; dna recombinant enzymes for the treatment of diseases; dna editable enzymes, in particular recombinases and integrases, for the treatment of diseases.;
Medical apparatus and instruments; laboratory apparatus for medical diagnostic purposes.;
Scientific and technological services and research, especially creation and application of bioinformatic algorithms and models; science and technology services, scientific and technological research, scientific development services, technological development, relating to the following sectors: gene, genome and cell editing, modulation, modification, engineering, regulation, repair and therapy for the development of pharmaceutical and biological preparations or medications for humans and diagnostic goods and services; consultancy services relating to development of pharmaceutical and biological preparations or medications for humans in the field of gene, genome and cell editing, modulation, modification, engineering, regulation, repair and therapy; genome engineering services; scientific research relating to genetics, scientific research, relating to the following sectors: genome editing; analytical laboratory services; medical laboratory services; scientific laboratory services; research laboratories; scientific research and development; development of pharmaceutical preparations and medicines; pharmaceutical products development; bioinformatic research for identification of target sequences for genome editing in a cell's DNA; bioinformatic research for identification of target sequences for genome editing in a cell's DNA by genome editable enzymes, DNA recombinant enzymes, dna editable enzymes, in particular recombinases and integrases; bioinformatic or computational analysis to identify target sequences in a cell's DNA; screening processes for the identification of genome editable enzymes, DNA recombinant enzymes, dna editable enzymes, in particular recombinases and integrases; research and development for the pharmaceutical industry; technological consultancy, relating to the following sectors: treatment of diseases by means of genome editable enzymes, dna recombinant enzymes, dna editable enzymes, in particular recombinases and integrases.;
Medical services; medical analysis relating to the treatment of persons; assay services, for treatment purposes; medical services and medical services, in relation to the following fields: genome editing; genetic counseling; therapy services; services for the preparation of medical reports; providing personalised healthcare and medical information; providing therapy recommendations; providing of information and counselling services, in relation to the following fields: medical services, health care services; therapy consultancy, in relation to the following fields: genome editing; counselling relating to recombinases and integrases for the treatment of diseases.;
Receba um e-mail a cada novo despacho publicado na RPI para o processo 501804706 — exigência, oposição, deferimento, prazo de pagamento — e quando alguém depositar uma marca parecida.
Monitorar esta marca Ver marcas parecidas3 despacho(s) publicado(s) na Revista da Propriedade Industrial.
26.15.25 Outros sólidos geométricos27.5.1 Letras apresentando um grafismo especial27.5.3 Letras em relevo ou sombreadas27.5.9 Grupos de letras apresentando grafismos diferentes